Cinacalcet
- TRADE NAMES: Mimpara (Amgen); Sensipar (Amgen)
- INDICATIONS: Secondary hyperparathyroidism, parathyroid carcinoma
- CLASS: Calcimimetic
- HALF-LIFE: 30–40 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Antifungal agents, Atomoxetine, Carvedilol, Codeine, Conivaptan, CYP2D6 substrates, CYP3A4 inhibitors, Dasatinib, Desipramine, Fesoterodine, Flecainide, Food, Itraconazole, Ketoconazole, Metoprolol, Nebivolol, PEG-Interferon, Tacrolimus, Tamoxifen, Tetrabenazine, Thioridazine, Tramadol, Tricyclic antidepressants, Voriconazole
PREGNANCY CATEGORY: C
Contra-indicated in patients with hypocalcemia.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 11/16/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric